Ozempic and Wegovy have the same active ingredient, semaglutide
In February 2025, the FDA announced that the shortage of semaglutide injectable products (Ozempic, Wegovy) has been resolved, Dulaglutide (Trulicity) shortage resolved in June 2025
Accessed 3 January 2025
Various MQC-targeted therapeutic strategies, such as enhancing mitochondrial biogenesis, promoting mitophagy, and regulating mitochondrial dynamics, together with combined approaches (e.g., gene therapy, cell-based therapies, and lifestyle modifications), have demonstrated promising protective effects in preclinical OA models
This means the desire to drink alcohol is diminished before the person thinks about it
However, so far across studies with GLP1R agonists , cardiovascular measurements such as blood pressure have seen improvements in general, with no significant increases in adverse cardiovascular effects seen in patients even after 2 years (In fact, decreases were seen), suggesting that the cardiovascular benefits of decreased body weight may overcome any potential harm that increases in heart rate by GLP1R agonists may cause